What You Should Know:
- Weight Watchers has unveiled a massive platform overhaul integrating GLP-1 prescription management with a redesigned app featuring an AI body scanner and a "Weight Health Score."
- The new "Med+" and "GLP-1 Success" programs offer specialized support for medication users, including nutrition plans to preserve muscle mass and direct access to board-certified physicians. The platform rollout begins globally on December 26, 2025, alongside a major brand
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
How Horizon Health and Qure.ai Are Using AI to Catch “Incidental” Lung Cancer
What You Should Know:
- Horizon Health Network, operating across New Brunswick, Canada, has partnered with global health tech leader Qure.ai to implement a comprehensive AI suite for lung cancer care.
- The strategic collaboration is designed to prepare the health system for a province-wide screening program while simultaneously deploying AI to detect "incidental" lung nodules in routine X-rays and CT scans. By integrating tools for detection, quantification, and patient
Read More
2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over
If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from "flashy, one-off experiments" to "top-down programs designed for measurable impact". Across the digital health landscape, executives agree that the "pilot era is ending," with the focus shifting entirely to systems that can be "governed, audited, and trusted" at scale.
The narrative for the coming year is no longer about the novelty of generative AI
Read More
PwC 2026 Outlook: Health Services M&A Poised for Rebound as AI Becomes “Core Driver” of Value
What You Should Know:
- According to PwC's 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
- The report highlights a strategic pivot among private equity investors away from reimbursement-heavy assets toward AI-enabled software and services that drive margin expansion without adding labor. With the IPO window reopening and "mega-funds" returning to offense, the winners in 2026 will be
Read More
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
- MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on "deep health" solutions that address diseases linked to environmental toxins and synthetic exposures.
- Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that move beyond symptom management
Read More
Mass General Brigham Spins Out AIwithCare: New AI Tool Doubles Clinical Trial Enrollment Rates
What You Should Know:
- Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly outperformed manual screening for determining a patient’s eligibility and enrolling them in a clinical trial.
- The tool, RECTIFIER (RAG-Enabled Clinical Trial Infrastructure for Inclusion Exclusion Review), was first developed and studied by
Read More
Ritten Raises $35M to Scale AI-Powered Behavioral Health Platform
What You Should Know:
- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
- This investment will support Ritten's expansion across mental health and addiction treatment providers spanning all levels of care.
A Unified Platform Purpose-Built for Behavioral Health
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Moving Beyond the Worklist: Agentic AI and Radiology’s Next Efficiency Leap
After years of flat or falling payment rates, radiology providers are being asked to do more with less. Medicare cuts continue to squeeze margins, and inflation-driven cost hikes in labor and supplies further strain budgets. At the same time, workforce shortages have left many radiology departments shorthanded and clinicians overextended. Meanwhile, the traditional follow-up worklist-centric model—essentially a growing to-do list of patients needing outreach, navigation, and scheduling—is
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
